目前国内外对癌症治疗均有很大进展，大多是以手术加放疗、化疗等综合治疗，但对部分失去手术机会的晚期肺癌患者来说一般的静脉化疗及单纯免疫治疗均碍于患者体质衰弱，化疗毒副作用大及疗效弱，而不能得到很好的治疗。近3年来我们采用经动脉导管介入化疗方法可避开以上种种弊 At present, there has been great progress in the treatment of cancer both at home and abroad. Most of these treatments are combined with surgery plus radiotherapy and chemotherapy. However, in patients with advanced stage lung cancer who have lost the chance of surgery, general intravenous chemotherapy and immunotherapy alone are detrimental to the patient’s constitution. , chemotherapy toxic side effects and weak efficacy, and can not get a good treatment. In the past 3 years, we have adopted transcatheter arterial catheterization chemotherapy to avoid the above-mentioned kinds of disadvantages.